Evaluating the impact of new anticoagulants in the hospital setting.

Although the incidence of bleeding events (including major and minor bleeds) was slightly higher for dabigatran and rivaroxaban compared to warfarin and enoxaparin, it did not reach statistical significance ( Table 6 ).

also in 111,027 other papers